Pinnacle Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.5M | Buy |
186,380
+17,750
| +11% | +$3.94M | 0.52% | 43 |
|
|
2025
Q4 | $38.5M | Sell |
168,630
-2,789
| -2% | -$635K | 0.49% | 47 |
|
|
2025
Q3 | $39.7M | Buy |
171,419
+2,859
| +2% | +$582K | 0.53% | 42 |
|
|
2025
Q2 | $31.3M | Buy |
168,560
+37,288
| +28% | +$6.93M | 0.45% | 50 |
|
|
2025
Q1 | $27.5M | Buy |
131,272
+1,802
| +1% | +$350K | 0.4% | 56 |
|
|
2024
Q4 | $23M | Buy |
129,470
+5,832
| +5% | +$1.07M | 0.31% | 73 |
|
|
2024
Q3 | $19.2M | Buy |
123,638
+5,635
| +5% | +$1.05M | 0.33% | 87 |
|
|
2024
Q2 | $20.2M | Sell |
118,003
-786
| -0.7% | -$130K | 0.32% | 85 |
|
|
2024
Q1 | $21.6M | Sell |
118,789
-4,849
| -4% | -$836K | 0.34% | 79 |
|
|
2023
Q4 | $19.2M | Sell |
123,638
-246
| -0.2% | -$35.9K | 0.32% | 88 |
|
|
2023
Q3 | $18.5M | Sell |
123,884
-711
| -0.6% | -$104K | 0.34% | 79 |
|
|
2023
Q2 | $16.8M | Buy |
124,595
+67,370
| +118% | +$9.88M | 0.29% | 101 |
|
|
2023
Q1 | $9.12M | Sell |
57,225
-603
| -1% | -$92.2K | 0.19% | 142 |
|
|
2022
Q4 | $9.35M | Sell |
57,828
-1,300
| -2% | -$199K | 0.2% | 135 |
|
|
2022
Q3 | $7.94M | Buy |
59,128
+1,000
| +2% | +$143K | 0.18% | 147 |
|
|
2022
Q2 | $8.9M | Sell |
58,128
-1,607
| -3% | -$246K | 0.19% | 141 |
|
|
2022
Q1 | $9.68M | Buy |
59,735
+2,780
| +5% | +$404K | 0.17% | 152 |
|
|
2021
Q4 | $7.71M | Buy |
56,955
+2,076
| +4% | +$245K | 0.13% | 171 |
|
|
2021
Q3 | $5.92M | Buy |
54,879
+2,521
| +5% | +$288K | 0.11% | 204 |
|
|
2021
Q2 | $5.9M | Buy |
52,358
+3,204
| +7% | +$361K | 0.11% | 196 |
|
|
2021
Q1 | $5.32M | Sell |
49,154
-250
| -0.5% | -$26.7K | 0.1% | 200 |
|
|
2020
Q4 | $5.29M | Buy |
49,404
+1,800
| +4% | +$173K | 0.11% | 190 |
|
|
2020
Q3 | $4.17M | Buy |
47,604
+1,551
| +3% | +$146K | 0.1% | 203 |
|
|
2020
Q2 | $4.52M | Buy |
46,053
+4,450
| +11% | +$392K | 0.11% | 188 |
|
|
2020
Q1 | $3.17M | Buy |
41,603
+4,361
| +12% | +$371K | 0.1% | 212 |
|
|
2019
Q4 | $3.3M | Sell |
37,242
-6,380
| -15% | -$530K | 0.07% | 249 |
|
|
2019
Q3 | $3.3M | Sell |
43,622
-6,946
| -14% | -$476K | 0.08% | 242 |
|
|
2019
Q2 | $3.68M | Sell |
50,568
-59,224
| -54% | -$4.65M | 0.09% | 236 |
|
|
2019
Q1 | $8.85M | Sell |
109,792
-17,057
| -13% | -$1.4M | 0.2% | 135 |
|
|
2018
Q4 | $11.7M | Sell |
126,849
-13,716
| -10% | -$1.21M | 0.3% | 94 |
|
|
2018
Q3 | $13.3M | Sell |
140,565
-13,751
| -9% | -$1.3M | 0.28% | 100 |
|
|
2018
Q2 | $14.3M | Sell |
154,316
-3,430
| -2% | -$335K | 0.29% | 96 |
|
|
2018
Q1 | $14.9M | Buy |
157,746
+2,581
| +2% | +$284K | 0.29% | 96 |
|
|
2017
Q4 | $15M | Sell |
155,165
-8,341
| -5% | -$786K | 0.29% | 90 |
|
|
2017
Q3 | $14.5M | Sell |
163,506
-436
| -0.3% | -$33.2K | 0.27% | 99 |
|
|
2017
Q2 | $11.9M | Buy |
163,942
+4,638
| +3% | +$312K | 0.23% | 111 |
|
|
2017
Q1 | $10.4M | Sell |
159,304
-46,838
| -23% | -$2.94M | 0.2% | 131 |
|
|
2016
Q4 | $12.9M | Sell |
206,142
-29,331
| -12% | -$1.79M | 0.26% | 105 |
|
|
2016
Q3 | $14.9M | Sell |
235,473
-20,067
| -8% | -$1.3M | 0.3% | 93 |
|
|
2016
Q2 | $15.8M | Buy |
255,540
+42,301
| +20% | +$2.58M | 0.34% | 83 |
|
|
2016
Q1 | $12.2M | Sell |
213,239
-1,774
| -0.8% | -$98.9K | 0.26% | 107 |
|
|
2015
Q4 | $12.7M | Buy |
215,013
+1,753
| +0.8% | +$101K | 0.27% | 102 |
|
|
2015
Q3 | $11.6M | Sell |
213,260
-153
| -0.1% | -$9.96K | 0.26% | 97 |
|
|
2015
Q2 | $14.3M | Buy |
213,413
+5,675
| +3% | +$370K | 0.27% | 99 |
|
|
2015
Q1 | $12.2M | Buy |
207,738
+42,354
| +26% | +$2.56M | 0.23% | 106 |
|
|
2014
Q4 | $10.8M | Buy |
165,384
+122
| +0.1% | +$7.69K | 0.21% | 113 |
|
|
2014
Q3 | $9.55M | Buy |
165,262
+7,268
| +5% | +$404K | 0.19% | 128 |
|
|
2014
Q2 | $8.92M | Buy |
157,994
+11,590
| +8% | +$608K | 0.17% | 135 |
|
|
2014
Q1 | $7.53M | Sell |
146,404
-7,528
| -5% | -$380K | 0.15% | 144 |
|
|
2013
Q4 | $8.13M | Buy |
153,932
+39,456
| +34% | +$1.94M | 0.16% | 133 |
|
|
2013
Q3 | $5.12M | Sell |
114,476
-1,247
| -1% | -$55.3K | 0.11% | 179 |
|
|
2013
Q2 | $4.78M | Buy |
+115,723
| New | +$5.06M | 0.11% | 178 |
|
Other funds holding ABBV
VCM
VPM
Pinnacle Associates's ABBV Position: Q1 2026 in Review
Pinnacle Associates increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $3.94M and bringing the position to 186,380 shares worth $40.5M. The position accounts for 0.52% of the portfolio, ranked #43.
Pinnacle Associates first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Pinnacle Associates held 186,380 shares of AbbVie worth $40.5M as of Q1 2026.
- Pinnacle Associates bought 17,750 AbbVie shares in Q1 2026, an estimated $3.94M.
- AbbVie made up 0.52% of Pinnacle Associates's portfolio in Q1 2026, its #43 holding.
- Pinnacle Associates first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.